Search Results

Biogen Clinical Trials Succeed in Eliminating Amyloid Deposits in the Brain Cells of Alzheimer’s Patients

Read about a new study that proves antibody treatments can remove amyloid deposit from the brain.
Duis dapibus nibh eu arcu viverra tempor. Fusce auctor sapien eu mauris malesuada vel euismod orci vulputate. Curabitur at orci id quam mollis rhoncus vitae volutpat urna. Nam ege… http://www.michaelmullan.us/blog/biogen-clinical-trials-succeed-eliminating-amyloid-deposits/

Can the GLUT1 protein Help Alzheimer’s Patients?

New study out of Keck School of Medicine proves that deficiency in protein that regulates flow of glucose hastens neurological degeneration seen in Alzheimer’s
Degenerative GLUT1 protein is a causal factor in neurological degeneration The GLUT1 protein serves as a driver of glucose across the blood-brain barrier. The blood-brain barr… http://www.michaelmullan.us/blog/can-glut1-protein-help-alzheimers-patients/

Dr. Michael Mullan participates in the NILVAD project - five year project will conduct Phase III clinical trials of the drug Nilvadipine

The first NILVAD project meeting took place on 15-16 February in Dublin. The five year project will conduct Phase III clinical trials of the drug Nilvadipine on some 500 people with mild to moderate Alzheimer’s disease in nine European countries. The tria…
The first NILVAD project meeting took place on 15-16 February in Dublin. The five year project will conduct Phase III clinical trials of the drug Nilvadipine on some 500 people wi… http://www.michaelmullan.us/blog/dr-michael-mullan-participates-in-the-nilvad-project-five-year-project-will-conduct-phase-iii-clinical-trials-of-the-drug-nilvadipine/